Peled Amnon (CIK 2048879) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-23). Recent activity: Buy SLXN (7,576 shares), Buy SLXN (661 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | Silexion Therapeutics Corp (SLXN) | Director | Buy | 7,576 | $0 |
| 2025-12-31 | Silexion Therapeutics Corp (SLXN) | Director | Buy | 661 | $0 |
Source: SEC Form 4 filings · as of 2026-02-23